Xinxing jihua International Trading CO.,LTD.
产品中心
PRODUCT CENTER
>
>
Y-shape PEG NHS Ester
全部产品分类

留言反馈

如果您对产品有任何疑问,或者对我们有任何意见建议,欢迎在此留言,我们将关注您的问题并尽快与您联系。

1 / 1
浏览量:
1313

Y-shape PEG NHS Ester

零售价
0.0
市场价
0.0
浏览量:
1313
产品编号
A0001
数量
-
+
产品代号
Y-PEG-NHS
产品纯度
≥ 95%
包装规格
1g, 10g, 100g等(特殊包装需收取分装费用)
分子量
2000 Da, 5000 Da, 10000 Da等
如需其他分子量,请联系 sales@jenkem.com 或 010-62983737

科研客户小批量一键采购地址(小于50克):

1
产品描述
参考文献

  Y型聚乙二醇NHS酯是JenKem的专利产品,具有2个PEG链和一个活性酯基因,可以用来生产蛋白或其他生物分子中的赖氨酸上的氨基进行反应。Y-NHS可以在PH=7-8的缓冲液中在较短的时间内与NH2进行聚乙二醇化。由于Y-NHS具有独特的空间结构使它更具有选择性。

  键凯科技提供分装服务,需要收取分装费用,如果您需要分装为其他规格请与我们联系。

  键凯科技同时提供其他分子量的Y型衍生物产品,如你需要请与我司sales@jenkem.com联系。

  键凯科技提供大批量生产产品及GMP级别产品,如需报价请与我们联系。

 

扫二维码用手机看
未找到相应参数组,请于后台属性模板中添加

  References:

  1. AlQahtani, A.D., et al., Production of “biobetter” glucarpidase variants to improve drug detoxification and antibody directed enzyme prodrug therapy for cancer treatment, European Journal of Pharmaceutical Sciences, 2019, 127, P. 79-91.

  2. Haruta, K., et al., A Novel PEGylation Method for Improving the Pharmacokinetic Properties of Anti-Interleukin-17A RNA Aptamers, Nucleic acid therapeutics, 2017, 27(1):36-44.

  3. Guo, L., et al., Application Instructions for Y-NHS-40K for Amine PEGylation, click link.

  4. Masao, H., et al., Chemically Modified Interleukin-6 Aptamer Inhibits Development of Collagen-Induced Arthritis in Cynomolgus Monkeys, Nucleic Acid Therapeutics, 2015.

  5. Winship, A.L., Interleukin-11 alters placentation and causes preeclampsia features in mice, Proc Natl Acad Sci U S A., 2015, 112(52):15928-33.

  6. Risitano, A.M., et al., Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria, Blood Mar, 2014, 123 (13) 2094-2101.

  7. Roccaro, Aldo M. et al., SDF-1 Inhibition Targets the Bone Marrow Niche for Cancer Therapy, Cell Reports, 2014, 9 (1), p: 118 – 128.

  8. Stefan, N., et al., Novel Prodrug-Like Fusion Toxin with Protease-Sensitive Bioorthogonal PEGylation for Tumor Targeting, Bioconjugate chemistry, 2014, 25.12: 2144-2156.

  9. Ashokan, A., et al., Multifunctional calcium phosphate nano-contrast agent for combined nuclear, magnetic and near-infrared in vivo imaging. Biomaterials, 2013, 34(29): p. 7143-7157.

  10. Khan, M.A., et al., Targeting complement component 5a promotes vascular integrity and limits airway remodeling, PNAS, 2013, 110(15) p:6061-6066.

  11. Dai, C.Y., et al., Preparation and evaluation of a new releasable PEGylated tumor necrosis factor-α (TNF-α) conjugate for therapeutic application, Science China Life Sciences, 2013, 56.1 : 51-58.

  12. Dai, C.Y., et al., Linkage with cathepsin B-sensitive dipeptide promotes the in vitro and in vivo anticancer activity of PEGylated tumor necrosis factor-alpha (TNF-α) against murine fibrosarcoma, Science China Life Sci, 2011, 54(2): 128–138.

  13. Menkhorst, E., et al., Vaginally Administered PEGylated LIF Antagonist Blocked Embryo Implantation and Eliminated NonTarget Effects on Bone in Mice, PLoS ONE, 2011, 6 (5) e19665.

  14. Cai, Y., et al., Separation of exenatide analogue mono-PEGylated with 40 kDA polyethylene glycol by cation exchange chromatography, Journal of Chromatography A, 2011, 1218:39, P. 6953-6960.

  15. Wang, Y-J., et al., PEGylation markedly enhances the in vivo potency of recombinant human non-glycosylated erythropoietin: A comparison with glycosylated erythropoietin, Journal of Controlled Release, 2010, 145:3, p. 306-313.

  16. Marcus, Y., et al., Turning Low-Molecular-Weight Drugs into Prolonged Acting Prodrugs by Reversible Pegylation: A Study with Gentamicin, Journal of Medicinal Chemistry, 2008, 51 (14), 4300-4305.

  17. Wang, S., et al., Y-type polyethylene glycol modified G-CSF and preparation method and use thereof. Patent CN200780051378, 2007.

  18. Zhou, W., et al., Interferon alpha 2a modified by polyethylene glycol, its synthesis process and application. Patent CN200780050541, 2007.

  19. Zhou, W., et al., Interferon alpha 2b modified by polyethylene glycol, its synthesis process and application. Patent CN200780050542, 2007.

  20. Zhou, W., et al., Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof. Patent CN200880009718, 2008.

产品咨询

留言应用名称:
产品咨询
描述:
TOP
搜索
确认
取消
JenKem

键凯科技的产品为您提高和改善药性,

为客户提供从候选药物筛选到申报临床研究的全过程服务!

联系我们

+86-010-82156767

+86-010-62983737

sales@jenkem.com

北京市海淀区西小口路66号中关村东升科技园C-1楼三层

WEBSITE

微信公众号

Copyright © 2001-2021  北京键凯科技股份有限公司  京ICP备05043698号-1

留言反馈

留言应用名称:
客户留言
描述:

语言选择